The estimated Net Worth of Howard Liang is at least $9.81 Milhão dollars as of 14 January 2021. Howard Liang owns over 14,000 units of BeiGene Ltd stock worth over $2,660,490 and over the last 9 years Howard sold BGNE stock worth over $7,152,582.
Howard has made over 16 trades of the BeiGene Ltd stock since 2016, according to the Form 4 filled with the SEC. Most recently Howard sold 446 units of BGNE stock worth $162,790 on 28 June 2021.
The largest trade Howard's ever made was exercising 1,497,200 units of BeiGene Ltd stock on 14 December 2020 worth over $1,302,564. On average, Howard trades about 80,337 units every 89 days since 2016. As of 14 January 2021 Howard still owns at least 12,600 units of BeiGene Ltd stock.
You can see the complete history of Howard Liang stock trades at the bottom of the page.
Howard's mailing address filed with the SEC is C/O MOURANT GOVERNANCE SERVICES (CAYMAN), 94 SOLARIS AVENUE, CAMANA BAY, GRAND CAYMAN, E9, KY1-1108.
Over the last 9 years, insiders at BeiGene Ltd have traded over $1,899,158,980 worth of BeiGene Ltd stock and bought 23,241,738 units worth $1,040,248,444 . The most active insiders traders include Bros. Advisors Lp667, L.P.B..., Investment Management, Ltd...., eBros. Advisors Lp Baker Bro.... On average, BeiGene Ltd executives and independent directors trade stock every 13 days with the average trade being worth of $33,382,815. The most recent stock trade was executed by Xiaobin Wu on 3 September 2024, trading 5,556 units of BGNE stock currently worth $1,053,695.
BeiGene is a biotechnology company that specializes in the development of drugs for cancer treatment. BeiGene has developed several pharmaceuticals, including tislelizumab, a checkpoint inhibitor, and zanubrutinib.
BeiGene Ltd executives and other stock owners filed with the SEC include: